Vagelos P Roy - Director at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Stock Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Vagelos P Roy since 7/4/2023

Holdings reported by Vagelos P Roy for Regeneron Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 312,578 $297 M $951.26 Apr 3, 2023 Direct
Common Stock 125,493 $119 M $951.26 Apr 3, 2023 by CLAT
Common Stock 23,461 $22.3 M $951.26 Apr 3, 2023 by Spouse as Trustee
Common Stock 3,609 $3.43 M $951.26 Apr 3, 2023 by trust for grandch
Common Stock 1,963 $1.87 M $951.26 Apr 3, 2023 By 401(k) Plan
Non-Qualified Stock Option (right to buy) 85,000 Feb 22, 2023 Direct Common Stock

Transactions reported by Vagelos P Roy for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership